Lahore: Highnoon Laboratories Limited has scheduled a meeting of its Board of Directors on March 26, 2025, at 11:30 a.m. The meeting will take place at the company's corporate office, located on the 9th Floor of Tricon Corporate Center in Lahore. During this meeting, the board is set to consider and approve the annual accounts for the period that ended on December 31, 2024, along with other agenda items.

In compliance with the regulations set forth by the Pakistan Stock Exchange (PSX), Highnoon Laboratories has announced a "Closed Period" from March 19, 2025, to March 26, 2025. This period restricts any dealings in the company's shares by directors, the CEO, or executives. According to information available from the Pakistan Stock Exchange (PSX), the closed period is a mandatory measure under section 5.6.1(d) of the PSX regulations, aimed at ensuring fair trading practices and preventing insider trading.

Highnoon Laboratories Limited operates within the designated market category of pharmaceuticals. The company, in adherence to regulatory stipulations, has formally communicated these developments to stakeholders. The announcement reflects a commitment to transparency and regulatory compliance, as the board reviews the company's financial performance for the previous year.